Search

Your search keyword '"Young, Carolyn"' showing total 1,132 results

Search Constraints

Start Over You searched for: Author "Young, Carolyn" Remove constraint Author: "Young, Carolyn"
1,132 results on '"Young, Carolyn"'

Search Results

6. Identification of a DNA methylation episignature for recurrent constellations of embryonic malformations

9. Diversity of Seed Endophytes: Causes and Implications

15. Diversity of Seed Endophytes: Causes and Implications

18. Physical and psychological aspects of multiple sclerosis: Revisiting the Multiple Sclerosis Impact Scale (MSIS-29).

19. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial

21. The Abecedarian Approach in a Low-Resource Urban Neighborhood in Canada: An Impact Evaluation in a Child Care Setting

22. Rasch analysis of the modified Fatigue Severity Scale in neuromuscular disorders and comparison between sex, age and diagnoses.

23. Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.

24. Rasch analysis of the Unidimensional Self‐Efficacy Scale in Neuromuscular Disorders and comparison between sex, age, and diagnoses.

25. Our current understanding of the biological impact of endometrial cancer mtDNA genome mutations and their potential use as a biomarker.

26. Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

27. Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change

28. Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial

38. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

41. Helping Faculty Work with International Writers across the Disciplines.

50. List of Contributors

Catalog

Books, media, physical & digital resources